Bringing the fundamentals into focus…
Back to REGENXBIO Inc.
How REGENXBIO Inc. stacks up
RGNX · against 463 other Healthcare companies of similar size
Overall
24/ 100
Near the bottom of its peers.
Ranked #413 of 464 · scores higher than 9% of peers
Bars: peers in each 10-point band of the overall score60 peers with an overall score of 20–29, including RGNX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around RGNX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 4 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 413 | 2.5B CNY (≈$355M) | 24 | 0 | 9 | 31 | 1 / 2 | |
| 413 | 487M USD | 24 | 8 | 63 | 12 | 2 / 2 | |
| 413 | 264M USD | 24 | 8 | 5 | 2 | 0 / 2 | |
| 413 | 825M USD | 24 | 8 | 86 | 1 | 2 / 2 | |
| 413 | 504M USD | 24 | 8 | 69 | 10 | 2 / 2 | |
| 413 | 588M USD | 24 | 8 | 60 | 10 | 2 / 2 | |
| 422 | 2.9B CNY (≈$411M) | 23 | 7 | 12 | 37 | 1 / 2 | |
| 422 | 530M USD | 23 | 8 | 0 | 4 | 0 / 2 | |
| 422 | 3.9B SEK (≈$385M) | 23 | 0 | 79 | 9 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score